TENX

TENAX THERAPEUTICS INC

TENX·88032L605·US·Common Stock·Healthcare - Biotechnology-13D/G

TENX (TENAX THERAPEUTICS INC) is held by 47 institutional investors as of Q1 2026. Largest holders: PRICE T ROWE ASSOCIATES INC /MD/ ($47.2M), Janus Henderson Group Ltd. ($29.1M), MORGAN STANLEY ($9.5M). Net institutional sentiment: Bullish.

47
Holders
Avg rating(3 Elite)
$175.1M
Total Value
95% (47)
Fund Consensus
41 buying - 2 selling
TENXSmart Money Verdict
View all
Held by 47 funds
3 elite
Who's Trading
ActivistFMR LLCFMR LLC14.9%Jul 8, 2026
ActivistT. Rowe Price Associates, Inc.T. Rowe Price Associates, Inc.2.2%Jun 5, 2026
ActivistMillennium Management LLCMillennium Management LLC5.1%May 20, 2026
ActivistSTStonepine Capital Management, LLC3.7%May 15, 2026
ActivistLGLogos Global Management LP3.0%May 15, 2026
ActivistBLBVF PARTNERS L P/IL10.0%May 15, 2026
InsiderRSRich StuartBuy $26KDec 9, 2025
InsiderRSRich StuartBuy $25KDec 8, 2025
InsiderGTGiordano Christopher ThomasBuy $4KNov 20, 2025
InsiderGTGiordano Christopher ThomasBuy $3KNov 19, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
3M$47.2M0.0%+53.68%
40
Increased
1.8M(+989.3%)$29.1M0.0%+59.94%
46
Increased
596,564(+0.0%)$9.5M0.0%+70.42%
28
Increased
540,126(+548.1%)$8.6M0.0%+72.12%
44
Increased
533,965(+26.1%)$8.5M0.0%+47.73%
34
Increased
533,889(+76.5%)$8.5M0.0%+106.36%
42
New
399,184$6.4M0.0%+53.68%
38
Increased
381,419(+563x)$6.1M0.0%+53.68%
44
Decreased
370,246(-2.1%)$5.9M0.1%+170.42%
0
Increased
352,572(+18.3%)$5.6M0.0%+84.00%
32
Increased
323,911(+125.8%)$5.2M0.0%+68.89%
44
Increased
322,600(+128.6%)$5.2M0.0%+50.34%
44
New
279,537$4.5M0.0%+53.68%
37
New
263,421$4.2M0.0%+53.68%
37
New
194,616$3.1M0.0%+53.68%
37
Increased
152,600(+21.5%)$2.4M0.0%+72.96%
31
Increased
152,516(+17.8%)$2.4M0.0%+66.82%
31
New
120,529$1.9M0.0%+53.68%
36
Increased
69,160(+24.2%)$1.1M0.0%+112.19%
31
Increased
68,588(+104.9%)$1.1M0.0%+49.96%
41

Showing 1-20 of 47

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used